Selinexor is developed by Karyopharm Therapeutics. Karyopharm Therapeutics is a biopharmaceutical company focused on global innovative drug development, specializing in the development of innovative drugs targeting nuclear export protein inhibitors.
The Selinexor of Celinosol is 20mg/tablet, 4*8 tablets/box. The price is approximately $387.
Selinexor's high-profile therapeutic drug has once again ignited a flame of ···【more】
Release date:2024-11-27Recommended:93
Dose adjustment regimen for selinexor in the treatment of diffuse large B-cell l···【more】
Release date:2024-11-26Recommended:133